CZ124092A3 - Process for preparing optically active (2s) or (2r)-endobicyclo-2.2.1-hepan-2-ole - Google Patents

Process for preparing optically active (2s) or (2r)-endobicyclo-2.2.1-hepan-2-ole

Info

Publication number
CZ124092A3
CZ124092A3 CS921240A CS124092A CZ124092A3 CZ 124092 A3 CZ124092 A3 CZ 124092A3 CS 921240 A CS921240 A CS 921240A CS 124092 A CS124092 A CS 124092A CZ 124092 A3 CZ124092 A3 CZ 124092A3
Authority
CZ
Czechia
Prior art keywords
hepan
endobicyclo
ole
optically active
preparing optically
Prior art date
Application number
CS921240A
Other languages
English (en)
Inventor
Nicholas A Saccomano
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CZ124092A3 publication Critical patent/CZ124092A3/cs
Publication of CZ280006B6 publication Critical patent/CZ280006B6/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CS921240A 1989-11-13 1989-11-13 Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu CZ280006B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/005228 WO1991007501A1 (en) 1989-11-13 1989-11-13 Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents

Publications (2)

Publication Number Publication Date
CZ124092A3 true CZ124092A3 (en) 1995-04-12
CZ280006B6 CZ280006B6 (cs) 1995-09-13

Family

ID=22215375

Family Applications (2)

Application Number Title Priority Date Filing Date
CS921240A CZ280006B6 (cs) 1989-11-13 1989-11-13 Způsob přípravy opticky aktivního (2S) nebo (2R)-endobicyklo-2.2.1heptan-2-olu
CS905609A CZ280011B6 (cs) 1989-11-13 1990-11-13 Opticky aktivní 5-(3-/(2S) nebo (2R)-exobicyklo /2.2.1/ hept-2-yloxy/-4-methoxyfenyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-on a způsob jeho přípravy

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS905609A CZ280011B6 (cs) 1989-11-13 1990-11-13 Opticky aktivní 5-(3-/(2S) nebo (2R)-exobicyklo /2.2.1/ hept-2-yloxy/-4-methoxyfenyl)-3,4,5,6-tetrahydropyrimidin-2(1H)-on a způsob jeho přípravy

Country Status (27)

Country Link
EP (2) EP0801135A1 (cs)
JP (1) JPH06104661B2 (cs)
KR (1) KR930004654B1 (cs)
CN (1) CN1040423C (cs)
AT (1) ATE158577T1 (cs)
AU (3) AU633157B2 (cs)
CA (1) CA2029705C (cs)
CZ (2) CZ280006B6 (cs)
DE (1) DE69031487T2 (cs)
DK (1) DK0428302T3 (cs)
EG (1) EG19860A (cs)
ES (1) ES2107420T3 (cs)
FI (1) FI105106B (cs)
GR (1) GR3025196T3 (cs)
HU (2) HU220962B1 (cs)
IE (2) IE904059A1 (cs)
IL (5) IL96261A (cs)
MY (1) MY104517A (cs)
NO (1) NO304838B1 (cs)
NZ (1) NZ236037A (cs)
PH (1) PH30255A (cs)
PL (4) PL164176B1 (cs)
PT (1) PT95855B (cs)
RU (1) RU2104306C1 (cs)
WO (1) WO1991007501A1 (cs)
YU (1) YU48413B (cs)
ZA (1) ZA909044B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007501A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
IE71647B1 (en) 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives
EP0570593B1 (en) * 1991-12-06 1998-09-09 Shionogi Seiyaku Kabushiki Kaisha Process for producing optically active norborneol
JP3100984B2 (ja) * 1992-12-02 2000-10-23 ファイザー・インク. 選択的pde▲下i▼▲下v▼阻害物質としてのカテコールジエーテル類
US5814651A (en) * 1992-12-02 1998-09-29 Pfizer Inc. Catechol diethers as selective PDEIV inhibitors
JP3431204B2 (ja) * 1993-04-22 2003-07-28 塩野義製薬株式会社 ノルボルナン型エステル・ヒドロラーゼ
CN1041436C (zh) * 1993-05-07 1998-12-30 佛山市制药一厂 一种稳定冯了性风湿跌打药酒的方法
US5482944A (en) * 1993-07-13 1996-01-09 Pfizer Inc. Pyrimidones and imidazolinones for treatment of shock
JPH1142095A (ja) * 1997-07-25 1999-02-16 Chisso Corp 新規なオキソジシクロペンタジエンの製造方法
KR100479019B1 (ko) * 1998-05-22 2005-08-29 씨제이 주식회사 캐테콜히드라존유도체,이의제조방법및그를함유한약제학적조성물
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
KR20040017246A (ko) 2001-06-29 2004-02-26 니켄 가가쿠 가부시키가이샤 사이클로알케논 유도체
ES2194588B1 (es) * 2001-07-13 2004-10-16 Astur Pharma S.A. Precursores opticamente puros de paroxetina.
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9580471B2 (en) 2011-03-01 2017-02-28 Synergy Pharmaceuticals, Inc. Process of preparing guanylate cyclase C agonists
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) * 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
US4732853A (en) * 1984-11-21 1988-03-22 President And Fellows Of Harvard College Method of making chiral epoxy alcohols
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
WO1991007501A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents

Also Published As

Publication number Publication date
IE980174A1 (en) 2000-02-23
AU645449B2 (en) 1994-01-13
AU3197993A (en) 1993-04-22
HU215441B (hu) 1999-04-28
HU220962B1 (hu) 2002-07-29
NZ236037A (en) 1992-08-26
EG19860A (en) 1996-03-31
DE69031487D1 (de) 1997-10-30
EP0428302A3 (en) 1992-05-13
PL164202B1 (pl) 1994-06-30
IL110564A (en) 1998-03-10
PL292069A1 (en) 1992-04-21
YU48413B (sh) 1998-07-10
PL164457B1 (pl) 1994-07-29
JPH06104661B2 (ja) 1994-12-21
PT95855B (pt) 1998-01-30
KR910009622A (ko) 1991-06-28
CA2029705A1 (en) 1991-05-14
IL110564A0 (en) 1994-11-11
FI922142A (fi) 1992-05-12
EP0801135A1 (en) 1997-10-15
PL164176B1 (pl) 1994-06-30
CZ560990A3 (en) 1995-04-12
RU2104306C1 (ru) 1998-02-10
CN1051905A (zh) 1991-06-05
ATE158577T1 (de) 1997-10-15
GR3025196T3 (en) 1998-02-27
AU6653590A (en) 1991-05-16
MY104517A (en) 1994-04-30
PL292070A1 (en) 1992-04-21
FI922142A0 (fi) 1992-05-12
IL110568A0 (en) 1994-11-11
WO1991007501A1 (en) 1991-05-30
PL287727A1 (en) 1992-02-24
CZ280011B6 (cs) 1995-09-13
AU633157B2 (en) 1993-01-21
KR930004654B1 (ko) 1993-06-02
HUT64604A (en) 1994-01-28
CN1040423C (zh) 1998-10-28
ZA909044B (en) 1992-06-24
NO921876D0 (no) 1992-05-12
HU9802988D0 (en) 1999-11-29
AU3292093A (en) 1993-04-22
FI105106B (fi) 2000-06-15
PL165132B1 (pl) 1994-11-30
CZ280006B6 (cs) 1995-09-13
ES2107420T3 (es) 1997-12-01
YU214290A (sh) 1992-12-21
DK0428302T3 (da) 1997-10-13
EP0428302B1 (en) 1997-09-24
PH30255A (en) 1997-02-05
DE69031487T2 (de) 1998-02-05
IL96261A (en) 1996-12-05
IE904059A1 (en) 1991-05-22
IL96261A0 (en) 1991-08-16
NO921876L (no) 1992-07-10
JPH03173871A (ja) 1991-07-29
PT95855A (pt) 1991-09-13
EP0428302A2 (en) 1991-05-22
IL110568A (en) 1995-10-31
NO304838B1 (no) 1999-02-22
CA2029705C (en) 1998-11-24

Similar Documents

Publication Publication Date Title
CZ124092A3 (en) Process for preparing optically active (2s) or (2r)-endobicyclo-2.2.1-hepan-2-ole
AU5291090A (en) Process for optical fiber drawing
AU7576687A (en) Apparatus for scanning an optical record carrier
GB8827460D0 (en) Method & apparatus for blowing optical fibre member
EP0304805A3 (en) Optical scanning apparatus for a transparent web of material
AU625144B2 (en) Production method for optical fiber base material
GB8822619D0 (en) Method of & apparatus for breaking optical fiber
JPS6469533A (en) Method and apparatus for manufacturing magnified beam optical fiber taper
EP0301791A3 (en) Light beam control arrangements for optical disc apparatus
AU4008589A (en) Optical beam scanning apparatus
AU624484B2 (en) Furnace and process for optical fiber drawing
GB2231679B (en) Optical beam scanning apparatus
AU2574288A (en) Optical fiber drawing apparatus
AU1404488A (en) Photodetector assembly for a laser scanning apparatus
GB8809595D0 (en) Method & apparatus for making optical fibre member
AU7166991A (en) Process for racemization of optically active arylethanolamines
HUT49210A (en) Optical arrangement for scanning laser beam apparatuses

Legal Events

Date Code Title Description
IF00 In force as of 2000-06-30 in czech republic
MM4A Patent lapsed due to non-payment of fee

Effective date: 20051113